Castle Biosciences (CSTL) announced that CEO Derek Maetzold will participate in a panel discussion at the 2025 BIO International Convention in Boston from June 16-19. The panel, titled 'Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to Entry,' will focus on challenges faced by precision medicine companies in commercializing diagnostic tests. The session will take place on June 17, 2025, from 11 a.m.-12 p.m. Eastern Time in Room 251. The panel will be moderated by Michael Ryan from McDermott Will & Emery and include industry experts Mara Aspinall from Illumina Ventures and Gillian Hooker from Concert. Castle Biosciences will also be represented at the City of Phoenix Pavilion (1639) and Texas Pavilion (2665).
Castle Biosciences (CSTL) ha annunciato che il CEO Derek Maetzold parteciper脿 a una tavola rotonda durante la BIO International Convention 2025 a Boston, dal 16 al 19 giugno. Il panel, intitolato "Promuovere test innovativi di stratificazione del rischio che influenzano le decisioni sui percorsi terapeutici: sfide nel superare le barriere all'ingresso", si concentrer脿 sulle difficolt脿 che le aziende di medicina di precisione incontrano nella commercializzazione dei test diagnostici. La sessione si terr脿 il 17 giugno 2025, dalle 11:00 alle 12:00 ora orientale, nella Sala 251. Il panel sar脿 moderato da Michael Ryan di McDermott Will & Emery e vedr脿 la partecipazione di esperti del settore come Mara Aspinall di Illumina Ventures e Gillian Hooker di Concert. Castle Biosciences sar脿 inoltre presente al City of Phoenix Pavilion (1639) e al Texas Pavilion (2665).
Castle Biosciences (CSTL) anunci贸 que su CEO, Derek Maetzold, participar谩 en un panel de discusi贸n en la Convenci贸n Internacional BIO 2025 en Boston, del 16 al 19 de junio. El panel, titulado "Avanzando pruebas innovadoras de estratificaci贸n de riesgo que impactan las decisiones en las v铆as de tratamiento: desaf铆os para superar las barreras de entrada", se enfocar谩 en los retos que enfrentan las empresas de medicina de precisi贸n para comercializar pruebas diagn贸sticas. La sesi贸n tendr谩 lugar el 17 de junio de 2025, de 11 a.m. a 12 p.m. hora del Este, en la Sala 251. El panel ser谩 moderado por Michael Ryan de McDermott Will & Emery e incluir谩 expertos de la industria como Mara Aspinall de Illumina Ventures y Gillian Hooker de Concert. Castle Biosciences tambi茅n estar谩 representada en el City of Phoenix Pavilion (1639) y en el Texas Pavilion (2665).
Castle Biosciences (CSTL) a annonc茅 que son PDG, Derek Maetzold, participera 脿 une table ronde lors de la Convention Internationale BIO 2025 脿 Boston, du 16 au 19 juin. Le panel, intitul茅 芦 Faire progresser les tests innovants de stratification des risques impactant les d茅cisions de parcours de traitement : d茅fis pour surmonter les barri猫res 脿 l'entr茅e 禄, se concentrera sur les d茅fis rencontr茅s par les entreprises de m茅decine de pr茅cision dans la commercialisation des tests diagnostiques. La session aura lieu le 17 juin 2025, de 11h 脿 12h, heure de l'Est, dans la salle 251. Le panel sera mod茅r茅 par Michael Ryan de McDermott Will & Emery et comprendra des experts du secteur comme Mara Aspinall d'Illumina Ventures et Gillian Hooker de Concert. Castle Biosciences sera 茅galement repr茅sent茅e au City of Phoenix Pavilion (1639) et au Texas Pavilion (2665).
Castle Biosciences (CSTL) gab bekannt, dass CEO Derek Maetzold an einer Podiumsdiskussion auf der BIO International Convention 2025 in Boston vom 16. bis 19. Juni teilnehmen wird. Das Panel mit dem Titel 鈥濬ortschritte bei innovativen Risiko-Stratifizierungstests, die Behandlungsentscheidungen beeinflussen: Herausforderungen bei der 脺berwindung von Markteintrittsbarrieren鈥� wird sich auf die Herausforderungen konzentrieren, denen sich Unternehmen der Pr盲zisionsmedizin bei der Kommerzialisierung diagnostischer Tests gegen眉bersehen. Die Sitzung findet am 17. Juni 2025 von 11:00 bis 12:00 Uhr Eastern Time im Raum 251 statt. Moderiert wird das Panel von Michael Ryan von McDermott Will & Emery, mit Branchenexperten wie Mara Aspinall von Illumina Ventures und Gillian Hooker von Concert. Castle Biosciences wird au脽erdem auf dem City of Phoenix Pavilion (1639) und dem Texas Pavilion (2665) vertreten sein.
Positive
None.
Negative
None.
FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc.聽(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The panel will explore the challenges precision medicine companies face in commercializing innovative diagnostic tests and discuss strategies for navigating today's market complexities while remaining focused on improving care for patients.
Panel Details: Title: Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to Entry Date & Time: Tuesday, June 17, 2025, from 11 a.m.-12 p.m. Eastern Time Location: Room 251 Focus Area: Diagnostics and Personalized Medicine Session Type: Breakout Session
Moderator: Michael Ryan, J.D., Partner, McDermott Will & Emery Panel Participants:
Derek Maetzold, Founder, President and CEO, Castle Biosciences
Castle is also a member of the City of Phoenix and Texas delegations attending BIO 2025. For information on Castle, please visit the City of Phoenix Pavilion (1639) or the Texas Pavilion (2665).
To register to attend BIO 2025, visit .
About BIO鈥� BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the鈥�, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.鈥�
About Castle Biosciences Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle鈥檚 current portfolio consists of tests for skin cancers, Barrett鈥檚 esophagus and uveal melanoma.聽Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit聽 and connect with us on聽,听,听 补苍诲听.鈥�
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact: Camilla Zuckero
Media Contact: Allison Marshall
Source: Castle Biosciences Inc.
FAQ
When and where is Castle Biosciences (CSTL) CEO speaking at BIO 2025?
Derek Maetzold will speak on Tuesday, June 17, 2025, from 11 a.m.-12 p.m. Eastern Time in Room 251 at the BIO International Convention in Boston.
What is the topic of Castle Biosciences' panel discussion at BIO 2025?
The panel will discuss challenges in commercializing innovative diagnostic tests and strategies for navigating market complexities while focusing on improving patient care.
Who are the other panelists joining Castle Biosciences CEO at BIO 2025?
The panel includes Mara Aspinall from Illumina Ventures and Gillian Hooker from Concert, with Michael Ryan from McDermott Will & Emery as moderator.
Where can attendees find Castle Biosciences at BIO 2025?
Castle Biosciences can be found at the City of Phoenix Pavilion (1639) and the Texas Pavilion (2665).
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
